These drugs, called checkpoint inhibitors, have been approved by the Food and drug Administration to treat advanced melanoma, Hodgkin lymphoma and cancers of the lung, kidney and bladder.
Methods:The effects of N-CWS on bladder carcinoma and on the activities of interleukin-2(IL-2) and NK cell were studied in syngenic mice bearingbladder carcinoma.